Long-Term Data Further Confirm SpaceOAR Hydrogel Quality-of-Life Benefits

Long-Term Data Further Confirm SpaceOAR Hydrogel Quality-of-Life Benefits
Prostate cancer patients who received the SpaceOAR hydrogel before radiation therapy continue to report benefits five years after treatment, including better urinary and sexual function, a new study reported. The study titled, “Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results,” was published in the International Journal of Radiation Oncology: Biology, Physics. “These long-term results further validate previous 3-year data of the SpaceOAR System and highlight the long-term bowel and sexual Quality of Life benefits it can provide to prostate cancer patients who are treated with radiotherapy,” Michael Pinkawa, MD, PhD, radiation oncologist at MediClin Robert Janker Klinik in Bonn, Germany, and lead author of the study, said in a press release. The SpaceOAR system, developed by Augmenix, was designed to temporarily create a protective space between the prostate and the rectum wall. By pushing the tissues apart, the injectable solution reduces the amount of radiation that reaches the rectum, minimizing its potentially damaging effects. The spacer is stable for three months, after which it returns to liquid form and is absorbed by the body. Recently, data from a three-year follow-up of a pivotal Phase 3 trial (
Subscribe or to access all post and page content.